Pharmacology, Biochemistry, and Behavior
Displaying 1 - 4 of 4
Chalmé, R. L., Rubin, E., Evans, S. M., Haney, M., & Foltin, R. W. (2025). Venlafaxine treatment is associated with improved mood, but not decreased cocaine self-administration, in depressed people who use cocaine. Pharmacology Biochemistry and Behavior, 247, 173918. https://doi.org/10.1016/j.pbb.2024.173918
Publication Date
Columbia Affiliation
Jones, J. D., Arout, C. A., Luba, R., Murugesan, D., Madera, G., Gorsuch, L., Schusterman, R., & Martinez, S. (2024). The influence of drug class on reward in substance use disorders. Pharmacology Biochemistry and Behavior, 240, 173771. https://doi.org/10.1016/j.pbb.2024.173771
Publication Date
Columbia Affiliation
View
Martinez, S., & Jones, J. D. (2023). A pilot study examining the relationship between chronic heroin use and telomere length among individuals of African ancestry. Pharmacology Biochemistry and Behavior, 231, 173631. https://doi.org/10.1016/j.pbb.2023.173631
Publication Date
Columbia Affiliation
Castillo, F., Jones, J. D., Luba, R. R., Mogali, S., Foltin, R. W., Evans, S. M., & Comer, S. D. (2022). Gabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder. Pharmacology Biochemistry and Behavior, 221, 173482. https://doi.org/10.1016/j.pbb.2022.173482
Publication Date
Columbia Affiliation